BioTraceIO 360

DEVICE2 trials

Sponsors

Techsomed Medical Technologies LTD

Conditions

Hepatocellular CarcinomaMetastatic Liver Cancer

Unknown Phase

Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures

TerminatedNCT05582018

Techsomed Medical Technologies LTDHepatocellular Carcinoma, Metastatic Liver Cancer

Start: 2023-09-05End: 2024-05-15Updated: 2025-09-15

Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)

WithdrawnNCT05641922

Techsomed Medical Technologies LTDHepatocellular Carcinoma, Metastatic Liver Cancer

Start: 2023-07-31End: 2023-12-31Updated: 2023-11-27